rs4252109

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000301.5(PLG):​c.669-14T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.255 in 1,419,248 control chromosomes in the GnomAD database, including 50,369 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4409 hom., cov: 32)
Exomes 𝑓: 0.26 ( 45960 hom. )

Consequence

PLG
NM_000301.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.993

Publications

20 publications found
Variant links:
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Gene-Disease associations (from GenCC):
  • hypoplasminogenemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • angioedema, hereditary, 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 6-160716631-T-G is Benign according to our data. Variant chr6-160716631-T-G is described in ClinVar as Benign. ClinVar VariationId is 1175104.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.286 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000301.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLG
NM_000301.5
MANE Select
c.669-14T>G
intron
N/ANP_000292.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLG
ENST00000308192.14
TSL:1 MANE Select
c.669-14T>G
intron
N/AENSP00000308938.9
PLG
ENST00000872438.1
c.669-14T>G
intron
N/AENSP00000542497.1
PLG
ENST00000872435.1
c.669-14T>G
intron
N/AENSP00000542494.1

Frequencies

GnomAD3 genomes
AF:
0.229
AC:
34800
AN:
152010
Hom.:
4412
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.170
Gnomad AMI
AF:
0.224
Gnomad AMR
AF:
0.202
Gnomad ASJ
AF:
0.289
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.107
Gnomad FIN
AF:
0.260
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.289
Gnomad OTH
AF:
0.244
GnomAD2 exomes
AF:
0.214
AC:
53652
AN:
251030
AF XY:
0.216
show subpopulations
Gnomad AFR exome
AF:
0.172
Gnomad AMR exome
AF:
0.124
Gnomad ASJ exome
AF:
0.277
Gnomad EAS exome
AF:
0.000708
Gnomad FIN exome
AF:
0.259
Gnomad NFE exome
AF:
0.295
Gnomad OTH exome
AF:
0.233
GnomAD4 exome
AF:
0.258
AC:
327187
AN:
1267120
Hom.:
45960
Cov.:
19
AF XY:
0.255
AC XY:
163607
AN XY:
641296
show subpopulations
African (AFR)
AF:
0.166
AC:
4956
AN:
29830
American (AMR)
AF:
0.131
AC:
5813
AN:
44484
Ashkenazi Jewish (ASJ)
AF:
0.277
AC:
6891
AN:
24888
East Asian (EAS)
AF:
0.000515
AC:
20
AN:
38834
South Asian (SAS)
AF:
0.114
AC:
9370
AN:
82282
European-Finnish (FIN)
AF:
0.261
AC:
13934
AN:
53322
Middle Eastern (MID)
AF:
0.257
AC:
1391
AN:
5422
European-Non Finnish (NFE)
AF:
0.291
AC:
271650
AN:
934382
Other (OTH)
AF:
0.245
AC:
13162
AN:
53676
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
12575
25150
37724
50299
62874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7990
15980
23970
31960
39950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.229
AC:
34806
AN:
152128
Hom.:
4409
Cov.:
32
AF XY:
0.224
AC XY:
16658
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.169
AC:
7034
AN:
41514
American (AMR)
AF:
0.201
AC:
3078
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
1002
AN:
3472
East Asian (EAS)
AF:
0.00174
AC:
9
AN:
5186
South Asian (SAS)
AF:
0.107
AC:
516
AN:
4818
European-Finnish (FIN)
AF:
0.260
AC:
2744
AN:
10574
Middle Eastern (MID)
AF:
0.228
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
0.289
AC:
19642
AN:
67956
Other (OTH)
AF:
0.242
AC:
510
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1347
2695
4042
5390
6737
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
362
724
1086
1448
1810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.271
Hom.:
8799
Bravo
AF:
0.225
Asia WGS
AF:
0.0550
AC:
194
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
16
DANN
Benign
0.63
PhyloP100
0.99
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4252109; hg19: chr6-161137663; COSMIC: COSV51987571; COSMIC: COSV51987571; API